Karen Lord has been appointed as a mesothelioma clinical nurse specialist at University Hospitals of Leicester NHS Trust.
The new full-time post has been made possible through funding from Mesothelioma UK, a charity dedicated to the asbestos-related cancer.
“There is a real need for more clinical trials and research in the region”
The Leicester post will be the 13th addition to Mesothelioma UK’s specialist nurse team, said the charity.
Ms Lord, who has been a nurse for over 30 years, will work with colleagues across the East Midlands to ensure access to specialist support and information.
For example, she will promote awareness about the options available to mesothelioma patients by “supporting, signposting and disseminating information”, said the charity. In addition, she will be “leading and generally offering appropriate clinical support”, it said.
Ms Lord trained at the Middlesex Hospital, before holding posts as a cancer nurse in Sheffield, Nottingham, London and Norfolk.
She then moved to Leicester where she worked in the specialist palliative care team. In addition, she completed a PhD in 2014 at Leicester University and will continue to participate in research as part of her new role.
Liz Darlison, Mesothelioma UK’s director of services and consultant nurse at University Hospitals of Leicester, said: “With the increasing number of mesothelioma patients across the country, Karen will focus on patient care, encouraging more clinical trials and research to take place, and taking the lead to support and educate more people on all aspects of mesothelioma.”
Specialist mesothelioma nurse appointed for Leicester
Ms Lord said she was “delighted” to be taking on her new role and highlighted her hope to promote research in the area.
“There is a real need for more clinical trials and research in the region to support the growing number of mesothelioma cases,” she said.
“I also hope to support other healthcare professionals about anything relevant to mesothelioma and ensure patients receive the highest quality care, support and treatment,” said Ms Lord.
She added: “Patients still need to be made aware about the treatment options available to them and I hope to provide the vital information and support for them.”